Neucruit combines an experienced team of leaders, medical researchers, software engineers and a scientific advisory board of key opinion leaders. Our platform improves accessibility for more remote and diverse patient populations, reducing site burden and de-risking clinical trial recruitment.
We use real-time data to help biopharmaceutical companies, site teams and investigators enhance site selection, optimise patient recruitment materials and reach groups that cannot be easily accessed through traditional methods.
Neucruit is on a mission to give innovators the power to connect with patients and fuel clinical development. To learn more, get in touch
Neucruit is an award-winning, government-backed venture that uses intelligent systems to build patient centred strategies that change lives. Our multidisciplinary team brings a wealth of knowledge, skills, experience and robust thinking, with a passion for producing first-class products with the highest ethical standards.
Backed by key opinion Leaders
Ex-Commercial Director at AstraZeneca UK, and Company Director at Oxford PharmaGenesis, a HealthScience communication consultancy.
Ex-VP of Global Clinical Development at Johnson & Johnson, and co-founder of the Institute of Clinical Research.
Founder of bioinformatics tools, DNAdigest and Repositive. COO at O2H Ventures, a leading biotech venture capital fund.
Managing Director at Strategy Health, digital health strategy at Mount Sinai Health System and Yale New Haven Hospital.
CEO of MDgroup. Over 20 years in global senior management across the biopharmaceutical and clinical services sector.
Director at Tufts Centre for Drug Development and CISCRP, leading policy research programs and clinical research ventures.